Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma?
US Neurology - United Kingdom
doi 10.17925/usn.2014.10.01.48
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
Touch Medical Media, Ltd.